ProCE Banner Activity

CE / CME

Put Your Obesity Management Skills to the Test—Advancing Care Through Interactive Patient Simulations

Patient Simulation

This interactive program will use the Edocate platform to work through 3 unique Patient SimX cases to test your skills in the management of patients with obesity and provide feedback from experts.

Nurses: 1.50 Nursing contact hours

Pharmacists: 1.50 contact hours (0.15 CEUs)

Physicians: Maximum of 1.50 AMA PRA Category 1 Credits

Released: November 28, 2022

Expiration: January 31, 2024

No longer available for credit.
Begin Activity

Share

Faculty

Megan Adelman

Megan Adelman, PharmD, BCPS, BCGP, CDCES

Clinical Pharmacist - Family Medicine
Center for Family Medicine
Cleveland Clinic Akron General
Akron, Ohio

Lisa Coco

Lisa Coco, MSN, CRNP, CDCES

Nurse Practitioner
Department of Endocrinology
Jefferson University
Philadelphia, Pennsylvania

Michael Jensen

Michael Jensen, MD

Tomas J. Watson, Jr. Professor in Honor
of Dr. Robert L. Frye
Endocrine Research Unit
Mayo Clinic
Rochester, Minnesota

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from

Novo Nordisk

Target Audience

This program is intended for adult endocrinologists, primary care physicians, nurse practitioners, and physician associates/physician assistants, and other healthcare professionals to manage patients with obesity.

Program Learning Goal

The goal of this education is not only to improve healthcare professionals’ knowledge and competence in diagnosing and managing patients with obesity, but also to allow them to demonstrate application of knowledge and improvement in clinical performance by working through real-world patient cases.

Learning Objectives

  • Assess patients based on the guideline-recommended criteria for diagnosis and treatment of obesity
  • Apply guideline recommendations, patient-specific factors, and preferences to select treatments for patients with obesity
  • Evaluate the need for treatment modification based on patient progress toward weight loss goals

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Faculty Disclosure

Primary Author

Megan Adelman, PharmD, BCPS, BCGP, CDCES

Clinical Pharmacist - Family Medicine
Center for Family Medicine
Cleveland Clinic Akron General
Akron, Ohio

Megan Adelman, PharmD, BCPS, BCGP, CDCES, has no relevant financial relationships to disclose.

Lisa Coco, MSN, CRNP, CDCES

Nurse Practitioner
Department of Endocrinology
Jefferson University
Philadelphia, Pennsylvania

Lisa Coco, MSN, CRNP, CDCES: consultant/advisor/speaker: AstraZeneca, Novo Nordisk, Xeris.

Michael Jensen, MD

Tomas J. Watson, Jr. Professor in Honor
of Dr. Robert L. Frye
Endocrine Research Unit
Mayo Clinic
Rochester, Minnesota

Michael D. Jensen, MD: researcher: Novo Nordisk.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
Credit Designation

CCO designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

Credit Designation

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.5 contact hours.

Physician Assistant/Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until November 27, 2023. PAs should only claim commensurate with the extent of their participation.

Continuing Pharmacy Education

Credit Designation

CCO designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-23-019-H01-P

Type of Activity: Application

Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Additional Information

Participation in this self-study activity should be completed in approximately 1.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from November 28, 2022, through January 31, 2024:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 100% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.